VALYSTR · Stock research
Listed on NasdaqCM. What the market is pricing into Vistagen Therapeutics, Inc. (VTGN) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $7.5M (as of 2026-11-11)
Opening the full page… All companies · Research guides · What a reverse DCF shows